Schedule 13G ownership disclosure

Kyverna Therapeutics, Inc.

Security class unavailable · CUSIP: 501976104

Event date: 2024-02-12

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
450,000
Percent of class
1.0000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-24-026552
Form type
SC 13G
Filer
Kyverna Therapeutics, Inc.
CIK
CIK 1994702
Filed
Feb 22, 2024
Reporting period
Feb 12, 2024
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub